Finance

Lists
Why is OBIO down 6.17%?
Dive Deeper
OBIO:NASDAQ
Orchestra Biomed Holdings Inc
$7.00
-6.17%
(-0.46) 1D
$7.00
0.00% (0.00)
After hours
Closed: Nov 19, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OBIO...
Open
$7.50
High
$7.63
Low
$6.96
Mkt. cap
550.93M
Avg. vol.
504.59K
Volume
0.00
52-wk high
$7.82
52-wk low
$3.46
EPS
-$0.91
Beta
0.56
Shares outstanding
78.70M
No. of employees
86
Open
$7.50
High
$7.63
Low
$6.96
Mkt. cap
550.93M
Avg. vol.
504.59K
Volume
0.00
52-wk high
$7.82
52-wk low
$3.46
EPS
-$0.91
Beta
0.56
Shares outstanding
78.70M
No. of employees
86
News stories
From web sources and news partners
About Orchestra Biomed Holdings Inc
CEO-
Employees86
Founded2018
Headquarters-
SectorHealth Care
IndustryMedical device
Analyst ratings
Based on 5 analysts giving stock ratings to OBIO in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for OBIO in the last 3 months.
Highest
Current $7.00
$15.00 (+114.29%)
Average
$12.40 (+77.14%)
Lowest
$11.00 (+57.14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew O'Brien
Piper Sandler
Buy
Maintained
$12.00
+71.4%
11/16/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$12.00
+71.4%
11/16/2026
Marie Thibault
BTIG
Buy
Maintained
$12.00
+71.4%
11/13/2026
Madison Elsaadi
B. Riley Securities
Buy
Reiterated
$11.00
+57.1%
10/02/2026
Josh Jennings
TD Cowen
Buy
Reiterated
$15.00
+114.3%
09/25/2026
Unknown Analyst
BTIG
Hold
Maintained
-
-
07/09/2026
Anderson Schock
B. Riley Securities
Buy
Reiterated
$10.00
+42.9%
05/18/2026
Matt Miksic
Barclays
Buy
Reiterated
$13.00
+85.7%
05/13/2026
Keay Nakae
Chardan Capital
Buy
Maintained
$20.00
+185.7%
03/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
30.92M
110.00K
88.00K
91.00K
Cost of goods sold
51.00K
32.00K
25.00K
28.00K
Cost of revenue
51.00K
32.00K
25.00K
28.00K
Research and development expenses
16.82M
15.78M
16.59M
17.73M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.29M
6.37M
5.83M
5.62M
Operating expense
24.11M
22.15M
22.42M
23.36M
Total operating expenses
24.16M
22.19M
22.44M
23.39M
Operating income
6.75M
-22.08M
-22.36M
-23.30M
Other non operating income
254.00K
-376.00K
-517.00K
-1.11M
EBT including unusual items
6.24M
-20.69M
-23.76M
-18.75M
EBT excluding unusual items
6.24M
-22.93M
-23.80M
-24.89M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
6.24M
-20.69M
-23.76M
-18.75M
Net profit margin
20.20%
-18,810.00%
-26,994.32%
-20,604.40%
Earnings per share
0.26
-0.33
-0.37
-0.41
Interest and investment income
752.00K
-
-
-
Interest expense
-1.52M
-480.00K
-927.00K
-488.00K
Net interest expenses
-763.00K
-480.00K
-927.00K
-488.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
6.84M
-21.99M
-22.26M
-23.20M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps